Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome

A subunit vaccine, RBD-S, is under development to prevent severe acute respiratory syndrome (SARS) caused by SARS coronavirus (SARS-CoV), which is classified by the US NIH as a category C pathogen. This vaccine is comprised of a recombinant receptor-binding domain (RBD) of the SARS-CoV spike (S) pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shibo, Bottazzi, Maria Elena, Du, Lanying, Lustigman, Sara, Tseng, Chien-Te Kent, Curti, Elena, Jones, Kathryn, Zhan, Bin, Hotez, Peter J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Special Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586247/
https://www.ncbi.nlm.nih.gov/pubmed/23252385
http://dx.doi.org/10.1586/erv.12.126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586247/
https://www.ncbi.nlm.nih.gov/pubmed/23252385
http://dx.doi.org/10.1586/erv.12.126

Ejemplares similares